Thrombolysis in acute ischaemic stroke - time for a rethink?
In the US the licence, or marketing authorisation, for alteplase is limited to 0-3 hours after onset of stroke, but some other countries - including the UK and Australia - have extended the licence to 4.5 hours. In an analysis article on thebmj.com Brian Alper, vice president of evidence based medicine research and development at Dynamed, and colleagues, interpret the evidence to suggest increased mortality with uncertain benefit for its use beyond three hours. Read their full analysis: http://www.bmj.com/content/350/bmj.h1075 (Source: The BMJ Podcast)
Source: The BMJ Podcast - March 18, 2015 Category: Journals (General) Authors: BMJ talk medicine Source Type: podcasts

The blockbuster sex drug for women; creating a feminist issue
A thrice failed antidepressant is at the centre of a new marketing campaign to win approval for what could become the world’s first blockbuster sex pill for women. Frustrated by the drug’s repeated rejection, proponents have orchestrated a fierce attack, accusing the regulator of unfairness, and enlisting support from several well connected... (Source: The BMJ Podcast)
Source: The BMJ Podcast - October 16, 2014 Category: Journals (General) Authors: BMJ talk medicine Source Type: podcasts

The blockbuster sex drug for women; creating a feminist issue
A thrice failed antidepressant is at the centre of a new marketing campaign to win approval for what could become the world’s first blockbuster sex pill for women. Frustrated by the drug’s repeated rejection, proponents have orchestrated a fierce attack, accusing the regulator of unfairness, and enlisting support from several well connected women’s organisations in the US. Critics counter that the campaign is exceedingly misleading, that it targets a desire disorder that does not exist, and that approval could see widespread overprescribing of a drug with marginal benefits and real safety concerns. Ray Moynihan ha...
Source: The BMJ Podcast - October 16, 2014 Category: General Medicine Authors: BMJ Group Source Type: podcasts

Is advice to cut down smoking wrong?
New NICE guidance says that smokers should be encouraged to cut down on the number of cigarettes they smoke, as well as trying to quit. In a head to head, published on bmj.com, Paul Aveyard, professor of behavioural medicine at the University of Oxford, says that reducing smoking is a worthwhile step towards cessation, but Gerard Hastings, professor of social marketing at Stirling and Open Universities, argues that the lifelong nicotine replacement therapy being recommended in support may benefit industry more than public health. Read the full head to head: http://www.bmj.com/content/348/bmj.g2787 (Source: The BMJ Podcast)
Source: The BMJ Podcast - May 23, 2014 Category: General Medicine Authors: BMJ Group Source Type: podcasts

Alcohol - The UK ’s billion unit pledge is worthless
The BMJ has been investigating the “cosy relationship” between the alcohol industry and the British government. In a series of articles Under the influence, journalist Jonathan Gornall has been looking into UK government’s consultation into introducing a minimum unit price for alcohol in England and Wales, and also at the wider responsibility deal between government and industry which is meant to champion public health. In his latest article, he looks at the billion unit pledge, and how it's actually being used as a marketing tool to attract new drinkers. Read all of the articles discussed on www.bmj.com/alcohol (Sou...
Source: The BMJ Podcast - May 21, 2014 Category: General Medicine Authors: BMJ Group Source Type: podcasts

Joint Replacements: Proper Selection
Dr. Harry Demos, an expert in joint replacements, explains how patients can intelligently filter through the numerous advertisements for joint replacement options. He points out that new marketing cannot replace proper discussion with a physician about the best approach for each individual patient. (Source: MUSC Bone and Joint Health (Orthopaedics) Podcast)
Source: MUSC Bone and Joint Health (Orthopaedics) Podcast - April 5, 2014 Category: Orthopaedics Authors: Medical University of South Carolina Source Type: podcasts

Physicians' Role in Drug Marketing Questioned
A major pharmaceutical company plans to stop paying doctors to promote its drugs, which may help curb industry bias but could also impede physician education, says Dr. Gerald Chodak. (Source: Medscape Diabetes & Endocrinology Podcast)
Source: Medscape Diabetes & Endocrinology Podcast - January 22, 2014 Category: Endocrinology Authors: Medscape Source Type: podcasts

Physicians' Role in Drug Marketing Questioned
A major pharmaceutical company plans to stop paying doctors to promote its drugs, which may help curb industry bias but could also impede physician education, says Dr. Gerald Chodak. (Source: Medscape Gastroenterology Podcast)
Source: Medscape Gastroenterology Podcast - January 22, 2014 Category: Gastroenterology Authors: Medscape Source Type: podcasts

What the hell is immunotherapy?
Join us as we welcome leadership from the Cancer Research Institute (Brian Brewer, Director of Marketing and Communications and Alexis Feldman, Chair of CRI's Young Philanthropists) to talk about the latest on this topic. Survivor spotlight on advocate/blogger Dan Duffy, co-founder of The Half Fund   (Source: The Stupid Cancer Show - Blog Talk Radio)
Source: The Stupid Cancer Show - Blog Talk Radio - January 21, 2014 Category: Cancer & Oncology Authors: Stupid Cancer Show Tags: Health Source Type: podcasts

What the hell is immunotherapy?
Join us as we welcome leadership from the Cancer Research Institute (Brian Brewer, Director of Marketing and Communications and Alexis Feldman, Chair of CRI's Young Philanthropists) to talk about the latest on this topic. Survivor spotlight on advocate/blogger Dan Duffy, co-founder of The Half Fund (Source: The Stupid Cancer Show - Blog Talk Radio)
Source: The Stupid Cancer Show - Blog Talk Radio - January 21, 2014 Category: Cancer & Oncology Authors: Stupid Cancer Show Tags: Health Source Type: podcasts

WHAT THE HELL IS IMMUNOTHERAPY? - Jan 21,2014
Join us as we welcome leadership from the Cancer Research Institute (Brian Brewer, Director of Marketing and Communications and Alexis Feldman, Chair of CRI's Young Philanthropists) to talk about the latest on this topic. Survivor spotlight on advocate/blogger Dan Duffy, co-founder of The Half Fund (Source: The Stupid Cancer Show - Blog Talk Radio)
Source: The Stupid Cancer Show - Blog Talk Radio - January 21, 2014 Category: Cancer & Oncology Authors: Stupid Cancer Show Tags: Health Source Type: podcasts

What the hell is immunotherapy? - 一月 21,2014
Join us as we welcome leadership from the Cancer Research Institute (Brian Brewer, Director of Marketing and Communications and Alexis Feldman, Chair of CRI's Young Philanthropists) to talk about the latest on this topic. Survivor spotlight on advocate/blogger Dan Duffy, co-founder of The Half Fund (Source: The Stupid Cancer Show - Blog Talk Radio)
Source: The Stupid Cancer Show - Blog Talk Radio - January 21, 2014 Category: Cancer & Oncology Authors: Stupid Cancer Show Tags: Health Source Type: podcasts

WHAT THE HELL IS IMMUNOTHERAPY? - Jan 21,2014
Join us as we welcome leadership from the Cancer Research Institute (Brian Brewer, Director of Marketing and Communications and Alexis Feldman, Chair of CRI's Young Philanthropists) to talk about the latest on this topic. Survivor spotlight on advocate/blogger Dan Duffy, co-founder of The Half Fund (Source: The Stupid Cancer Show - Blog Talk Radio)
Source: The Stupid Cancer Show - Blog Talk Radio - January 14, 2014 Category: Cancer & Oncology Authors: Stupid Cancer Show Tags: Health Source Type: podcasts

Joint Replacements: Proper Selection
Dr. Harry Demos, an expert in joint replacements, explains how patients can intelligently filter through the numerous advertisements for joint replacement options. He points out that new marketing cannot replace proper discussion with a physician about the best approach for each individual patient. (Source: MUSC Bone and Joint Health (Orthopaedics) Podcast)
Source: MUSC Bone and Joint Health (Orthopaedics) Podcast - September 21, 2013 Category: Orthopaedics Authors: Medical University of South Carolina Source Type: podcasts